Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Oseltamivir Phosphate 75 mg Capsules
NCT05083325Phase 1Completed
- Sponsor
- Laboratorios Andromaco S.A.
- Start
- Oct 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of oseltamivir in influenza (2 arms), sponsored by Laboratorios Andromaco S.A. Primary endpoints: Area Under the Plasma Concentration-Time Curve From Time Zero to Time t, Area Under the Plasma Concentration-Time Curve From Time Zero to Infinite and 2 more. Started Oct 2021; status: completed.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05083325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05083325.